We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Foreign API Manufacturing Dominance Requires Long-Term Federal Intervention: Report
Foreign API Manufacturing Dominance Requires Long-Term Federal Intervention: Report
The domination of the U.S. active pharmaceutical ingredient (API) supply chain by manufacturers based in China, India and other countries cannot be addressed without the federal government’s long-term intervention, an analysis from the Olin Business School at Washington University in St. Louis concludes.